| |
American On Sale
Sectors: Basic Materials
, Consumer Staples
, Finance
, Medical
Symbols: BUD, CBH, CGI, DNA, HBHC, IPS, MEDI
Author
Related RSS Feeds
As highlighted in BusinessWeek, and illustrated by the recent acquisition of Anheuser-Busch by InBev, the United States is on sale. The weak stock market and even weaker U.S. dollar are allowing foreign buyers to purchase U.S. companies at discount prices. In the past five years, 2,331 U.S. firms with a total value of $772.3 billion were purchased by foreign buyers, according to data provider Capital IQ. In 2007, 614 U.S. firms, valued at $294.4 billion, were acquired by foreign entities, up from 541 deals valued at $155.1 billion for 2006, and 226 firms valued at $49.6 billion in 2003. While foreign buying slowed some with the slowing global economy in 2008, there has still been 266 foreign deals announced year-to-date valued at $121 billion. Not surprisingly, bankers and M&A specialists expect the deals to continue and even accelerate if the dollar continues to be weak against the Euro. Foreign buyers also seem to have easier access to credit, compared to their American counterparts. Even those American companies who can obtain credit are less likely to do so given the uncertain economic environment. Who is next? It is difficult to tell, but the types of business purchased are being affected by the economy. Right now very stable businesses with good brands are being looked at. Companies similar to past and present takeovers, such as Anheuser-Busch, Genentech, Lucent Technologies, MedImmune, John Hancock, Commerce Bancorp, IPSCO, and the Thompson Corporation will be targets. If the economy were to improve, companies affected by the slowdown in the economy, and currently a little too risky given the environment, may also start to be considered, right at the point business starts to pick-up. Until the U.S. credit and housing problems are behind us, there may not be much some of these companies can do. Something to think about when you are having you next cold glass of InBev.
Subscribe to Email Alerts  or RSS feeds  for articles from more than 300 contributors and press releases, SEC filings and full text news from thousands of sources.
Related Stories
- Agriculture Boom Goes Bust: The Real Reasons Fertilizer Stocks Are Tanking
Oct 06, 2008 01:34 PM
- Movers: Wachovia, Wells Fargo, Citigroup, AIG
Oct 06, 2008 10:56 AM
- Best Perfomers Over Last Quarter
Oct 06, 2008 02:19 AM
- The News & Observer, Raleigh, N.C., Sue Stock Column: From Taking Stock
Oct 05, 2008 06:01 AM
- Three Growth Stocks That Are Posing As Value Stocks
Oct 04, 2008 02:07 PM
Related Press Releases
- Genentech and OSI Pharmaceuticals Announce Topline Results from Phase III Study Evaluating the Combination of Avastin and Tarceva as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer
Oct 06, 2008 01:30 AM
- Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: DISH, DNA, RT, LEA, IRM, ERES
Oct 03, 2008 10:20 AM
- Anheuser-Busch Previews Strong Third Quarter Results(1)
Oct 03, 2008 08:23 AM
- Capital Increase Information Trading Update
Oct 03, 2008 04:02 AM
- Genentech, GlycArt and Roche Enter into Collaboration Agreement for Potential Cancer Therapy
Oct 03, 2008 01:31 AM
Releated SEC Filings
Bookmark This Article
Email Article
Send this article by email
 
|
|
|